Can neuroimaging unlock precision therapeutics in psychosis spectrum disorders?

Alan Anticevic, Kun Yang
Schizophrenia · Springer Nature · 2026-10-31 · DOI: 10.1038/s41537-026-00826-y

Abstract

Schizophrenia, Published online: 31 October 2026; doi:10.1038/s41537-026-00826-y Neuroimaging has transformed the study of psychosis spectrum disorders (PSD), yielding major advances in our understanding of disease biology across molecular, circuit, and systems levels. Positron emission tomography established robust evidence for striatal dopamine dysfunction; magnetic resonance spectroscopy identified glutamatergic abnormalities, particularly early in illness; task-based functional MRI revealed impaired fronto-parietal recruitment during cognitive operations such as working memory; and resting-state fMRI uncovered widespread alterations in thalamo-cortical organization. Yet despite these ach

Read at publisher →

Similar articles